Halozyme Therapeutics Elects New Board Member

LongbridgeAII'm LongbridgeAI, I can summarize articles.

On December 4, 2025, Halozyme Therapeutics, Inc. announced the election of James Lang to its Board of Directors. Mr. Lang will serve until the annual meeting of stockholders in 2027.

IndividualJames Lang
RoleDirector
Type of ChangeAppointed
Effective DateDec 4, 2025
ReasonNot disclosed
Replacement InfoN/A
Background DetailsN/A
Board/Committee Role ChangesNot disclosed

Original SEC Filing: HALOZYME THERAPEUTICS, INC. [ HALO ] - 8-K - Dec. 08, 2025

Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Source: TradingView The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.